Clinical Trial Update: A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a combined Tdap booster to a licensed Td vaccine has completed, assessing protection against diphtheria, tetanus, and pertussis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Tdap vaccine (combined diphtheria-tetanus-acellular pertussis vaccine) (diphtheria-tetanus-acellular pertussis vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED